Arcturus Therapeutics Holdings (ARCT) Receivables - Net (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) has disclosed Receivables - Net for 8 consecutive years, with $5.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 40.01% year-over-year to $5.6 million, compared with a TTM value of $5.6 million through Dec 2025, up 40.01%, and an annual FY2025 reading of $5.6 million, up 40.01% over the prior year.
- Receivables - Net was $5.6 million for Q4 2025 at Arcturus Therapeutics Holdings, down from $8.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $92.5 million in Q1 2023 and bottomed at $2.0 million in Q1 2021.
- Average Receivables - Net over 5 years is $15.8 million, with a median of $4.8 million recorded in 2024.
- The sharpest move saw Receivables - Net surged 2405.64% in 2023, then plummeted 87.61% in 2024.
- Year by year, Receivables - Net stood at $3.4 million in 2021, then fell by 17.91% to $2.8 million in 2022, then skyrocketed by 1060.06% to $32.1 million in 2023, then tumbled by 87.61% to $4.0 million in 2024, then surged by 40.01% to $5.6 million in 2025.
- Business Quant data shows Receivables - Net for ARCT at $5.6 million in Q4 2025, $8.0 million in Q3 2025, and $17.2 million in Q2 2025.